Indian journal of medical ethics
-
Indian J Med Ethics · Jul 2020
ReviewHydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
The world is going through an unprecedented medical emergency with no effective remedy for the SARS-CoV2 virus causing Covid-19. Two drugs used for other indications in the past, hydroxychloroquine (HCQ) and remdesivir (RDV), are sought to be repurposed to treat Covid-19. Both these drugs have received emergency use authorisation by the US Food and Drug Administration. In this review, we critically analyse the identification of and subsequent events concerning these two drugs as potential treatment options for Covid-19, and conclude by raising some ethical issues that require serious thought from the global scientific community concerned with using these two drugs against Covid-19.
Key Words: Covid-19, hydroxychloroquine, remdesivir, USFDA, emergency use authorisation
. -
The National Drug Policy (NDP), 1982, of Bangladesh was expected to make available essential, good quality drugs at affordable prices. This article gives an overview of the situation today, more than two decades after the Drugs (Control) Ordinance, 1982, was promulgated to implement the NDP. While there have been some successes, many of the goals of this initiative are yet to be achieved. Inadequate supply of essential drugs, substandard quality, uncontrolled drug prices and inappropriate uses of drugs are major problems in Bangladesh.
-
Indian J Med Ethics · Oct 2007
ReviewPublic-private partnerships and global health equity: prospects and challlenges.
Health equity remains a major challenge to policymakers despite the resurgence of interest to promote it. In developing countries, especially, the sheer inadequacy of financial and human resources for health and the progressive undermining of state capacity in many under-resourced settings have made it extremely difficult to promote and achieve significant improvements in equity in health and access to healthcare. In the last decade, public-private partnerships have been explored as a mechanism to mobilise additional resources and support for health activities, notably in resource-poor countries. ⋯ This paper examines the viability of public-private partnerships for improving global health equity and highlights some key prospects and challenges. The focus is on global health partnerships and excludes domestic public-private mechanisms such as the state contracting out publicly-financed health delivery or management responsibilities to private partners. The paper is intended to stimulate further debate on the implications of public-private partnerships for global health equity.
-
After the Consumer Protection Act, 1986, came into effect, a number of patients have filed cases against doctors. This article presents a summary of legal decisions related to medical negligence: what constitutes negligence in civil and criminal law, and what is required to prove it.